Cargando…

PARP inhibitors

Poly (ADP-ribose) polymerases, abbreviated as PARPs, are a group of familiar proteins that play a central role in DNA repair employing the base excision repair (BER) pathway. There about 17 proteins in this family out of which the primary nuclear PARPs are PARP-1, PARP-2, PARP-3, and tankyrases 1 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anwar, Maheen, Aslam, Hafiz Muhammad, Anwar, Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300021/ https://www.ncbi.nlm.nih.gov/pubmed/25606064 http://dx.doi.org/10.1186/s13053-014-0024-8

Ejemplares similares

Fahr’s syndrome: literature review of current evidence
por: Saleem, Shafaq, et al.
Publicado: (2013)

c-Met inhibitors
por: Mughal, Anum, et al.
Publicado: (2013)

PARP inhibitors: current status and implications for anticancer therapeutics
por: Usmani, Hadi, et al.
Publicado: (2013)

Hedgehog pathway inhibitors – current status and future prospects
por: Sheikh, Asfandyar, et al.
Publicado: (2012)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
por: Yang, Xiao-Dong, et al.
Publicado: (2021)

VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status
por: Bizzaro, Francesca, et al.
Publicado: (2021)

Ethical concerns regarding intersex
por: Aslam, Hafiz Muhammad, et al.
Publicado: (2013)

Is the bell ringing for another outbreak of Crimean-Congo hemorrhagic fever in Pakistan?
por: Waris, Abdul, et al.
Publicado: (2022)

RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells
por: Zhao, Yahui, et al.
Publicado: (2021)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Influenza immunization and surveillance in Saudi Arabia
por: Hashem, Anwar M.
Publicado: (2016)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Comment on “Transmission Model of Hepatitis B Virus with Migration Effect”
por: Zeb, Anwar, et al.
Publicado: (2015)

Is ‘Tea’ a real culprit behind lower urinary tract symptoms (LUTS) in men?
por: Javed, Danish, et al.
Publicado: (2021)

Monkeypox virus outbreak: a brief timeline
por: Anwar, F., et al.
Publicado: (2022)

A medical student’s perspective on motivating medical students for social accountability
por: BIJU, PRINCY, et al.
Publicado: (2021)

Large Hernia of Umbilical Cord Misdiagnosed as Omphalocele
por: Waqas Ali, Syed, et al.
Publicado: (2015)

Re “The Effect of Mode of Anaesthesia on Outcomes After Elective Endovascular Repair of Abdominal Aortic Aneurysm”
por: Chaudhuri, Arindam, et al.
Publicado: (2020)

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1
por: Wang, Jiyan, et al.
Publicado: (2022)

New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies
por: Syam, Yasmin M., et al.
Publicado: (2022)

Future of Community Medicine in India
por: Azhar, Gulrez Shah, et al.
Publicado: (2009)

Coronary slow flow: Benign or ominous?
por: Anwar, Mohammed Omer, et al.
Publicado: (2016)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2022)

In reply Asif M et al.
por: Asif, Muhammad, et al.
Publicado: (2021)

Isolated APTT prolongation—not always a bleeding risk in acute paediatric burns surgery
por: Nizamoglu, M., et al.
Publicado: (2014)

Reverse distal femoral locking compression plate a salvage option in nonunion of proximal femoral fractures
por: Siddiqui, Yasir Salam, et al.
Publicado: (2017)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Disability, Depression and Disc Surgery: Lets be Careful with the Evidence
por: Shamim, Muhammad Shahzad
Publicado: (2011)

Safety of powered dermatome during the COVID-19 pandemic
por: Noblet, Timothy Michael, et al.
Publicado: (2021)

Long-Term Survival of Three Fungal Species in Lyophilized Human Blood Plasma
por: Elkadi, Omar Anwar, et al.
Publicado: (2021)

Assessing the relation between alcohol consumption and risk of disease and mortality
por: Alam, Benyamin, et al.
Publicado: (2021)

Role of biliary complications in chronic graft rejection after living donor liver transplantation
por: Obed, Aiman, et al.
Publicado: (2022)

Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)
por: Nakai, Hidekatsu, et al.
Publicado: (2023)

Socio-demographic Factors Associated with Inhabitants’ View Related to Vaccines in Indonesia
por: HARAPAN, Harapan, et al.
Publicado: (2017)

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials
por: Alecu, Iulian, et al.
Publicado: (2018)

Author response to ‘Comment on “Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer” (Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639)’
por: Hettle, Robert, et al.
Publicado: (2023)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ka417ect61d9557ugc1cf1v27s